| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/13/2004 | US6720180 Epsin 3, a novel protein closely related to, but distinct from previously described epsins. this protein plays an important role in activated epithelial cells during tissue morphogenesis. |
| 04/13/2004 | US6720158 Splice variants of BRCA1 |
| 04/13/2004 | US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
| 04/13/2004 | US6719982 Transcriptional activation is prevented; nervous system disorders; gene therapy; genetic engineering and expression |
| 04/13/2004 | US6719979 Avian-paramyxovirus nucleotide sequences for use in the detection and treatment of avian viral diseases |
| 04/13/2004 | US6719974 Heat shock protein-based vaccines and immunotherapies |
| 04/13/2004 | US6719969 High speed hepatocyte proliferation and liver regeneration after injury caused by acetominophen overdose or surgery; side effect reduction of gene therapy |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/13/2004 | CA2182397C Endotoxin reduction or removal process |
| 04/08/2004 | WO2004029617A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 04/08/2004 | WO2004029287A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | WO2004029281A2 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals |
| 04/08/2004 | WO2004029278A2 Aav itr-mediated modulation |
| 04/08/2004 | WO2004029259A1 Baculovirus vector, method of constructing baculovirus vector and gene transfer method |
| 04/08/2004 | WO2004029246A2 Integrase cofactor |
| 04/08/2004 | WO2004029244A1 Animal cells having chimeric receptor and utilization thereof |
| 04/08/2004 | WO2004029229A2 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | WO2004029219A2 Cell-based rna interference and related methods and compositions |
| 04/08/2004 | WO2004029213A2 Compositions and methods for delivery of short interfering rna and short hairpin rna |
| 04/08/2004 | WO2004029212A2 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | WO2004029075A2 Peptide nucleic acids having improved uptake and tissue distribution |
| 04/08/2004 | WO2004029070A2 Methods for blocking adipocyte differentiation and triglyceride accumulation with dual-specificity tyrosine- (y) - phosphorylation regulated kinase 4 (dyrk4) inhibitors |
| 04/08/2004 | WO2004028635A1 Ocular gene therapy |
| 04/08/2004 | WO2004028560A1 Nucleic acid coated particles |
| 04/08/2004 | WO2004028556A1 Sustained release preparation for treating coronary stenosis or obstruction |
| 04/08/2004 | WO2004028554A2 Skrp, astray, string, vacm associated with metabolic control |
| 04/08/2004 | WO2004028546A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | WO2004028471A2 Influenza therapeutic |
| 04/08/2004 | WO2004028458A2 Antisense modulation of microsomal prostaglandin e2 synthase expression |
| 04/08/2004 | WO2004028442A2 Use of excipients to increase dna uptake by swine muscle cells |
| 04/08/2004 | WO2004028339A2 Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues |
| 04/08/2004 | WO2004028239A2 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 04/08/2004 | WO2004011624A9 Double stranded rna structures and constructs, and methods for generating and using the same |
| 04/08/2004 | WO2004007764A3 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/08/2004 | WO2004003182A3 Homozygous stem cells isolated from pathogenic oocytes |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2004000877A3 Peptides derived from the rabies virus glycoprotein g, ligands of the low-affinity receptor of neurotrophins (p75ntr) and applications thereof |
| 04/08/2004 | WO2003106619A3 Multifunctional polypeptides |
| 04/08/2004 | WO2003102185A3 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003094617A3 Use of vegf for treating bone defects |
| 04/08/2004 | WO2003093469A3 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 04/08/2004 | WO2003092600A3 Site specific listeria integration vectors and methods for using the same |
| 04/08/2004 | WO2003087122A3 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| 04/08/2004 | WO2003087021A3 Nanoparticle delivery systems and methods of use thereof |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003078597A3 Tissue engineering |
| 04/08/2004 | WO2003077852A3 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β |
| 04/08/2004 | WO2003072820A3 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 04/08/2004 | WO2003065006A3 Methods and compositions for treating cancer |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003059262A3 Method and composition for treating and preventing hiv infection and aids |
| 04/08/2004 | WO2003059153A3 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system |
| 04/08/2004 | WO2003046581A3 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers |
| 04/08/2004 | WO2003038112B1 A composition and method to alter lean body mass and bone properties in a subject |
| 04/08/2004 | WO2003022123A9 Methods of kidney transplantation utilizing developing nephric tissue |
| 04/08/2004 | WO2003012030A3 Isoform-selective inhibitors and activators of pde3 cyclic |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002090545A3 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 04/08/2004 | WO2002056918B1 Method of enhancing delivery of a therapeutic nucleic acid |
| 04/08/2004 | WO2002030470A8 Methods and compositions for nucleic acid delivery |
| 04/08/2004 | US20040068268 Devices and methods for the restoration of a spinal disc |
| 04/08/2004 | US20040068095 Comprises polypeptide for diagnosis, prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 04/08/2004 | US20040067907 Process for delivery of polynucleotides to the prostate |
| 04/08/2004 | US20040067904 Gene therapy for prostate cancer: sensibilization of cells to dna damaging drugs and radiation |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067887 Nucleotide sequences; drug screening; antibody to protein |
| 04/08/2004 | US20040067883 Prevent gene expression; anticancer agents |
| 04/08/2004 | US20040067882 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/08/2004 | US20040067587 Process for generating multilayered particles |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067524 Chlamydia protein, gene sequence and uses thereof |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067509 Method of identifying dna encoding physiologically active polypeptide in mammalian body |
| 04/08/2004 | US20040067491 Diagnosis of diseases associated with metabolism |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067242 Multi-subtype FIV vaccines |
| 04/08/2004 | US20040067222 Regulation of glucocorticoid concentration |
| 04/08/2004 | US20040067218 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissue |
| 04/08/2004 | US20040067217 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 04/08/2004 | CA2523618A1 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | CA2500468A1 Influenza therapeutic |
| 04/08/2004 | CA2500397A1 Aav itr-mediated modulation |
| 04/08/2004 | CA2500224A1 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | CA2500210A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | CA2499533A1 Use of excipients to increase dna uptake by swine muscle cells |
| 04/08/2004 | CA2499188A1 Cell-based rna interference and related methods and compositions |
| 04/08/2004 | CA2494899A1 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/07/2004 | EP1405916A1 Recombinant vaccinia virus incapable of expressing the A41L gene |
| 04/07/2004 | EP1405074A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404872A2 Method of selecting a dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 04/07/2004 | EP1404863A1 PIBs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404845A2 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 04/07/2004 | EP1404843A2 Regulation of human nek-like serine/threonine protein kinase |
| 04/07/2004 | EP1404841A2 Cyp1b1 nucleic acids and methods of use |
| 04/07/2004 | EP1404834A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |